New Wave Ventures

Poolside is an artificial intelligence platform that offers foundation concepts and infrastructure. It aims to unlock humanity's potential by pursuing AGI for software creation, with the fundamental belief that the transitional path for humanity to AGI is by building specific capabilities instead of a general-purpose approach. It also helps users utilize the power of software creation and understand future systems.

Regenerys Ltd. specializes in developing and selling regenerative medicine products focused on bioprocessing and biostorage. The company offers several innovative products, including Myskin, which uses cultured cells from a patient's own skin for treating serious burns and hard-to-heal wounds, and Cryoskin, which employs autologous cells for burn treatment. Additionally, Regenerys provides Adiposet, a service that enhances cosmetic outcomes in breast cancer surgeries and other aesthetic procedures by enabling the storage and return of adipose tissue. The company also delivers third-party bioprocessing and biostorage services through its laboratories. Serving both NHS and private healthcare providers, Regenerys operates primarily in the United Kingdom and Europe. Established in 2011, the company is headquartered in Cambridge, United Kingdom.

Xerion Healthcare Limited is a biotechnology company based in Thame, United Kingdom, specializing in the development and commercialization of nanoparticle treatments for cancer. Founded in 2015, the company focuses on enhancing the efficacy of conventional radiotherapy by utilizing nanoparticles made from titanium dioxide, a non-toxic semiconductor material. These nanoparticles are injected into tumors prior to standard radiotherapy, where they amplify the generation of free radicals produced by X-rays, thereby improving treatment outcomes. Xerion Healthcare is particularly concentrated on developing its innovative technology for head, neck, and pancreatic cancers, aiming to provide more effective therapies while minimizing side effects for patients.

Spectromics Limited, established in 2014 and headquartered in Manchester, UK, specializes in developing diagnostic systems to guide antibiotic treatment. The company offers a point-of-prescription test for bacterial infections, which helps healthcare professionals determine the appropriate antibiotic therapy by identifying antimicrobial susceptibility and resistance during patient appointments. This innovative approach aims to eliminate ineffective empirical prescriptions and improve patient outcomes.

Surface Generation Ltd. is a high-tech manufacturing company based in Oakham, United Kingdom, with additional facilities in North America and Asia. Established in 2002, the company specializes in developing and commercializing composite processing equipment for industries such as aerospace, automotive, and consumer electronics. Surface Generation is known for its patented Production to Functional Specification (PtFS) technology, which allows manufacturers to optimize their use of composite materials like carbon fiber, resulting in lightweight, energy-efficient products. The company provides tailored manufacturing solutions, including the production of sub-element components and demonstrator articles, as well as custom equipment for various applications, including oil and gas and academic research.

Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.

Nanna Therapeutics Limited, established in 2012 and headquartered in Cambridge, UK, is a biotechnology company focused on developing drugs for age-related diseases such as mitochondrial, neurodegenerative, cardiovascular/metabolic, joint/tissue diseases, and cancer. As of April 2020, the company operates as a subsidiary of Astellas Pharma Europe Ltd. Nanna Therapeutics employs a unique approach by targeting fundamental cellular processes to create innovative treatments for these conditions, with a particular emphasis on mitochondria, the energy source in every cell. The company's proprietary drug discovery platform, TIME (Totally Integrated Medicines Engine), combines advanced technologies like microfluidics and artificial intelligence to accelerate drug development and disrupt traditional methods of creating new medicines.

Endomag is a medical technology company focused on enhancing cancer care standards globally. Founded in 2007 as a spin-out from the University of Houston and University College London, the company is headquartered in Cambridge, United Kingdom. Endomag develops innovative magnetic sensing technology that provides minimally invasive surgical guidance, which helps physicians accurately target and remove tumors. Its key products, including the Sentimag probe, Magseed marker, and Magtrac node marker, are utilized by leading physicians and cancer centers worldwide. The company's mission is to enable women with breast cancer to avoid unnecessary surgeries and achieve better outcomes when surgery is required. To date, Endomag has assisted over 70,000 women globally in accessing more precise and less invasive breast cancer care through its network of distributors across Europe, the Middle East, Africa, and Australasia.

Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.

SPARKL Limited, founded in 2012 and headquartered in London, United Kingdom, specializes in providing transaction router solutions that ensure service level agreements on business-level transactions. The company's transaction router operates at Layer 7, enabling self-provisioning of business transactions for clients. SPARKL also designs and develops the SPARKL Sequencing Engine, which manages the behavior of distributed machines, systems, and applications using a declarative Clear Box configuration. This engine facilitates intelligent collaboration among these components, generating a tamper-proof audit trail for regulatory compliance and system performance. SPARKL collaborates with partners such as Cisco and Intel to market its products globally.

Endomag is a medical technology company focused on enhancing cancer care standards globally. Founded in 2007 as a spin-out from the University of Houston and University College London, the company is headquartered in Cambridge, United Kingdom. Endomag develops innovative magnetic sensing technology that provides minimally invasive surgical guidance, which helps physicians accurately target and remove tumors. Its key products, including the Sentimag probe, Magseed marker, and Magtrac node marker, are utilized by leading physicians and cancer centers worldwide. The company's mission is to enable women with breast cancer to avoid unnecessary surgeries and achieve better outcomes when surgery is required. To date, Endomag has assisted over 70,000 women globally in accessing more precise and less invasive breast cancer care through its network of distributors across Europe, the Middle East, Africa, and Australasia.

Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.

Tapit is a leading company in the contactless communications sector, specializing in near-field communications (NFC) technology. Established in 2011, Tapit collaborates with major global brands such as Google, Microsoft, Samsung, and Visa to implement and manage contactless infrastructure, including NFC tags, beacons, and QR codes. The company's technology simplifies content management by using encoded NFC chips embedded in physical objects, allowing users to engage with consumers directly via their smartphones in various environments, such as retail spaces and outdoor media. Tapit's solutions enable companies to create, deliver, manage, and analyze consumer interactions in real-time, enhancing the overall customer experience while streamlining communication processes.

Atto is a company that specializes in online identity verification services, focusing on identity proofing and verification through its IDaaS platform. This platform facilitates the brokering of verified personal attributes and multi-factor authentication, aiding various sectors such as healthcare, recruitment, gaming, retail banking, and consumer finance. Atto's solutions enhance customer onboarding processes by addressing challenges related to risk management, compliance, and fraud, while also enabling businesses to assess customer affordability and verify account information. The company connects to over 5,500 banks across 30 countries, supporting Open Banking initiatives. With a growing client base and recent collaborations with major financial institutions, Atto aims to streamline the application process for lenders and other businesses, ultimately improving customer experience. Founded in 2010 and based in Edinburgh, Atto also maintains offices in New York, London, and Sydney.

Surrey NanoSystems Limited is a manufacturer of nanoscale materials, specializing in advanced super-black coatings, most notably Vantablack. This unique coating is applied using vacuum-deposition technology and is designed for a variety of applications, including stray light suppression, sensors, telescopes, and architectural lighting. Vantablack enhances the performance of electro-optical imaging systems in sectors such as space and defense, automotive safety, and luxury goods. The company also provides solutions for calibration sources and aesthetic applications in cinematography and architecture. Founded in 2006 and headquartered in Newhaven, United Kingdom, Surrey NanoSystems was originally known as CEVP Limited before rebranding in December 2006.

Netmania Solutions, operating under Enhanced Telecommunications Ltd, specializes in device management solutions with a focus on standards-based technologies. Since its inception in 2001, the company has been actively involved in the delivery and deployment of TR-069, a protocol that helps operators enhance customer experiences, reduce churn, and improve profitability. Netmania develops both software and hardware services tailored for a diverse range of industries, including Internet service providers, cable operators, education, healthcare, and enterprises of various sizes. Its offerings encompass software development services such as product development, data migration, and online systems, positioning Netmania as a key player in the telecommunications and technology sectors.

Endomag is a medical technology company focused on enhancing cancer care standards globally. Founded in 2007 as a spin-out from the University of Houston and University College London, the company is headquartered in Cambridge, United Kingdom. Endomag develops innovative magnetic sensing technology that provides minimally invasive surgical guidance, which helps physicians accurately target and remove tumors. Its key products, including the Sentimag probe, Magseed marker, and Magtrac node marker, are utilized by leading physicians and cancer centers worldwide. The company's mission is to enable women with breast cancer to avoid unnecessary surgeries and achieve better outcomes when surgery is required. To date, Endomag has assisted over 70,000 women globally in accessing more precise and less invasive breast cancer care through its network of distributors across Europe, the Middle East, Africa, and Australasia.

Orthogem Limited is a company based in Nottingham, United Kingdom, that specializes in the development and manufacturing of synthetic bone grafts. Founded in 2001, Orthogem utilizes its patented Tripore technology platform to produce a range of synthetic bone grafts (SBGs) designed for various clinical applications, including spinal, oral, and craniofacial surgery. Its product offerings include TriPore Granules, TriPore MPA, and TriPore Blocks, which are engineered to promote optimal bone remodeling through their osteoconductive and bioactive properties. Orthogem’s materials address multiple medical challenges, such as fractures, congenital disorders, traumatic injuries, and bone cancer, ensuring reliable resorption during procedures like lumbar spine fusion.

Aeristech Limited is a company based in Kenilworth, United Kingdom, specializing in the development of electric air compressors for the automotive industry. Founded in 2006, Aeristech designs innovative products such as electric superchargers that provide continuous air pressure and flow, full electric turbochargers aimed at enhancing engine efficiency and downsizing, and fuel cell air compressors that maintain consistent air pressure across varying conditions. The company also manufactures components for high-speed electric motors used in hydrogen fuel cells, internal combustion engines, and various industrial applications. Its offerings include motor accelerators, hydrogen fuel compressors, electric superchargers, turbochargers, and refrigerants for battery cooling in the battery electric vehicle market. Aeristech's technology enables more efficient fuel combustion at lower rates, contributing to advancements in automotive performance and sustainability.